COMP <GO>
HEI vs TMO // 10Y YIELD & FRED MACRO BETA
Heico Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: HEI 8
— TMO 7
▲ 10Y YIELD & FRED MACRO BETA LEADER: HEI
LAST: $321.36 (-1.53%) • MKT CAP: $45.61B
macro-sensitivity
0.96
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
macro-sensitivity
0.94
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HEI VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HEI | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.80% | 41.00% | -1.20 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.60% | 9.30% | +4.30 | HEI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 43.5x | 30.4x | +13.10 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 1.89% | 2.40% | -0.51 | TMO | /fcf-yield <GO> |
| Operating Margin | 22.70% | 17.40% | +5.30 | HEI | /operating-margins <GO> |
| Net Profit Margin | 15.40% | 15.10% | +0.30 | HEI | /net-margins <GO> |
| Revenue Growth (YoY) | 16.30% | 3.90% | +12.40 | HEI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.07% | 0.24% | -0.17 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.53 | 4.50 | +4.03 | HEI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | HEI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.70% | +0.10 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.6 | 59.1 | +1.42 | HEI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.96 | 0.94 | +0.02 | HEI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 55.5x | 36.3x | +19.20 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $45.61B | $262.22B | -$216.61B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HEI REV | TMO REV | HEI GROSS % | TMO GROSS % | HEI FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.49B | $44.56B | 39.8% | 44.0% | $861.4M | $6.29B |
| FY 2024 | $3.86B | $42.88B | 38.9% | 44.0% | $614.1M | $7.27B |
| FY 2023 | $2.97B | $42.86B | 44.0% | 44.0% | $315.2M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HEI // BETA 0.96
TMO // BETA 0.94